Pro- and anti-inflammatory balance of septic patients is associated with severity and outcome

dc.catalogadorpau
dc.contributor.authorDougnac Labatut, Alberto
dc.contributor.authorCastro López, Ricardo
dc.contributor.authorRiquelme, Arnoldo
dc.contributor.authorCalvo, M.
dc.contributor.authorEugenin, E.
dc.contributor.authorArellano, M.
dc.contributor.authorPattillo, A.
dc.contributor.authorRegueira Heskia, Tomás
dc.contributor.authorMercado Flores, Marcelo Esteban
dc.contributor.authorAndresen Hernández, Max Alfonso
dc.date.accessioned2023-07-21T17:46:11Z
dc.date.available2023-07-21T17:46:11Z
dc.date.issued2007
dc.description.abstractPurpose: To study infl ammatory profi le in patients with sepsis, severe sepsis and septic shock with regards to organ dysfunction and outcome, and to identify a pattern associated with more catastrophic course of illness, organ failure and risk of death. Material and methods: Twenty-nine consecutive patients with sepsis admitted to a medical Intensive Care Unit of a tertiary university hospital (November 2002-December 2003). Plasmatic levels of interleukin-6 (IL-6) and interleukin-10 (IL10) as pro-infl ammatory and anti-infl ammatory markers were measured at baseline, 12, 24 and 48 hours of evolution. Results: There is a positive association between higher levels of IL-6 and severity of the septic process, organ dysfunctions and risk of death, statistically signifi cant at anytime (at baseline, 12, 24 and 48 hours, p <0.05). Higher IL-6/IL-10 ratios associate signifi cantly with risk of death at 24 hours (RR=1.45 if higher or equal to the median). Conclusions: Plasmatic biomarkers measurement during the initial phase of sepsis may help to individualize therapy. An evaluation at 24 h based on IL-6/IL-10 ratio may anticipate a more aggressive infl ammatory profi le. These patients would specially benefi t from immunomodulating therapies to improve survival.
dc.fechaingreso.objetodigital2024-05-07
dc.format.extent9 páginas
dc.fuente.origenORCID
dc.identifier.issn1410-7767
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-34547662425&partnerID=MN8TOARS
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/74254
dc.information.autorucEscuela de Medicina; Dougnac Labatut, Alberto; S/I; 54554
dc.information.autorucEscuela de Medicina; Castro López, Ricardo; 0000-0002-0978-9891; 4537
dc.information.autorucEscuela de Medicina; Regueira Heskia, Tomás; S/I; 18434
dc.information.autorucEscuela de Medicina; Mercado Flores, Marcelo Esteban; S/I; 18889
dc.information.autorucEscuela de Medicina; Andresen Hernández, Max Alfonso; 0000-0003-1874-1416; 54274
dc.issue.numero3
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final107
dc.pagina.inicio99
dc.revistaCritical Care and Shockes_ES
dc.rightsacceso abierto
dc.subjectInfl ammation
dc.subjectSepsis
dc.subjectInterleukin
dc.subjectSeverity
dc.subjectOutcome
dc.titlePro- and anti-inflammatory balance of septic patients is associated with severity and outcomees_ES
dc.titlePro- and anti-inflammatory balance of septic patients is associated with severity and outcome
dc.typeartículo
dc.volumen10
sipa.codpersvinculados54554
sipa.codpersvinculados4537
sipa.codpersvinculados18434
sipa.codpersvinculados18889
sipa.codpersvinculados54274
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
document Pro- and Anti-Infl ammatory Balance.pdf
Size:
446.12 KB
Format:
Adobe Portable Document Format
Description: